deaths (OS)

mBC - TNBC - L2 - all population breast cancer - triple negative mBC-Triple negative (TNBC) - 2nd Line (L2) mBC - TNBC - L2 - all population

versus Standard of Care (SoC)
olaparib vs. Standard of Care (SoC) 1 0.90 [0.66; 1.23], 1 RCT, I2=0%
inconclusive result